205 related articles for article (PubMed ID: 27078158)
1. Retinoid X Receptor Agonists Upregulate Genes Responsible for the Biosynthesis of All-Trans-Retinoic Acid in Human Epidermis.
Wu L; Chaudhary SC; Atigadda VR; Belyaeva OV; Harville SR; Elmets CA; Muccio DD; Athar M; Kedishvili NY
PLoS One; 2016; 11(4):e0153556. PubMed ID: 27078158
[TBL] [Abstract][Full Text] [Related]
2. The retinoid X receptor has a critical role in synthetic rexinoid-induced increase in cellular all-trans-retinoic acid.
Belyaeva OV; Klyuyeva AV; Vyas A; Berger WK; Halasz L; Yu J; Atigadda VR; Slay A; Goggans KR; Renfrow MB; Kane MA; Nagy L; Kedishvili NY
PLoS One; 2024; 19(4):e0301447. PubMed ID: 38557762
[TBL] [Abstract][Full Text] [Related]
3. Next-generation retinoid X receptor agonists increase ATRA signaling in organotypic epithelium cultures and have distinct effects on receptor dynamics.
Melo N; Belyaeva OV; Berger WK; Halasz L; Yu J; Pilli N; Yang Z; Klyuyeva AV; Elmets CA; Atigadda V; Muccio DD; Kane MA; Nagy L; Kedishvili NY; Renfrow MB
J Biol Chem; 2023 Jan; 299(1):102746. PubMed ID: 36436565
[TBL] [Abstract][Full Text] [Related]
4. Effects on gene expression in rat liver after administration of RXR agonists: UAB30, 4-methyl-UAB30, and Targretin (Bexarotene).
Vedell PT; Lu Y; Grubbs CJ; Yin Y; Jiang H; Bland KI; Muccio DD; Cvetkovic D; You M; Lubet R
Mol Pharmacol; 2013 Mar; 83(3):698-708. PubMed ID: 23292798
[TBL] [Abstract][Full Text] [Related]
5. Regulation of retinoid-mediated signaling involved in skin homeostasis by RAR and RXR agonists/antagonists in mouse skin.
Gericke J; Ittensohn J; Mihály J; Alvarez S; Alvarez R; Töröcsik D; de Lera AR; Rühl R
PLoS One; 2013; 8(4):e62643. PubMed ID: 23638129
[TBL] [Abstract][Full Text] [Related]
6. A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitro.
Williams AP; Waters AM; Stewart JE; Atigadda VR; Mroczek-Musulman E; Muccio DD; Grubbs CJ; Beierle EA
J Surg Res; 2018 Aug; 228():54-62. PubMed ID: 29907230
[TBL] [Abstract][Full Text] [Related]
7. Prevention of KLF4-mediated tumor initiation and malignant transformation by UAB30 rexinoid.
Jiang W; Deng W; Bailey SK; Nail CD; Frost AR; Brouillette WJ; Muccio DD; Grubbs CJ; Ruppert JM; Lobo-Ruppert SM
Cancer Biol Ther; 2009 Feb; 8(3):289-98. PubMed ID: 19197145
[TBL] [Abstract][Full Text] [Related]
8. The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axis.
Chou CF; Hsieh YH; Grubbs CJ; Atigadda VR; Mobley JA; Dummer R; Muccio DD; Eto I; Elmets CA; Garvey WT; Chang PL
J Dermatol Sci; 2018 Jun; 90(3):343-356. PubMed ID: 29599065
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CRABPI in suprabasal keratinocytes enhances the proliferation of epidermal basal keratinocytes in mouse skin topically treated with all-trans retinoic acid.
Tang XH; Vivero M; Gudas LJ
Exp Cell Res; 2008 Jan; 314(1):38-51. PubMed ID: 17727842
[TBL] [Abstract][Full Text] [Related]
10. UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts.
Garner EF; Stafman LL; Williams AP; Aye JM; Goolsby C; Atigadda VR; Moore BP; Nan L; Stewart JE; Hjelmeland AB; Friedman GK; Beierle EA
J Neurooncol; 2018 Nov; 140(2):209-224. PubMed ID: 30132166
[TBL] [Abstract][Full Text] [Related]
11. Marked improvement induced in photoaged skin of hairless mouse by ER36009, a novel RARgamma-specific retinoid, but not by ER35794, an RXR-selective agonist.
Sakuta T; Kanayama T
Int J Dermatol; 2006 Nov; 45(11):1288-95. PubMed ID: 17076708
[TBL] [Abstract][Full Text] [Related]
12. Src is a novel potential off-target of RXR agonists, 9-cis-UAB30 and Targretin, in human breast cancer cells.
Kim MS; Lim DY; Kim JE; Chen H; Lubet RA; Dong Z; Bode AM
Mol Carcinog; 2015 Dec; 54(12):1596-604. PubMed ID: 25328014
[TBL] [Abstract][Full Text] [Related]
13. All-trans retinoic acid potentiates cisplatin-induced kidney injury in rats: impact of retinoic acid signaling pathway.
Elsayed AM; Abdelghany TM; Akool el-S; Abdel-Aziz AA; Abdel-Bakky MS
Naunyn Schmiedebergs Arch Pharmacol; 2016 Mar; 389(3):327-37. PubMed ID: 26659823
[TBL] [Abstract][Full Text] [Related]
14. Murine oncogenicity and pharmacokinetics studies of 9-cis-UAB30, an RXR agonist, for breast cancer chemoprevention.
Kapetanovic IM; Horn TL; Johnson WD; Cwik MJ; Detrisac CJ; McCormick DL
Int J Toxicol; 2010; 29(2):157-64. PubMed ID: 20335511
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid ameliorates photoaged skin through RAR‑mediated pathway in mice.
Li Z; Niu X; Xiao S; Ma H
Mol Med Rep; 2017 Nov; 16(5):6240-6247. PubMed ID: 28849147
[TBL] [Abstract][Full Text] [Related]
16. Effect of retinoid status on the messenger ribonucleic acid expression of nuclear retinoid receptors alpha, beta, and gamma, and retinoid X receptors alpha, beta, and gamma in the mouse testis.
Gaemers IC; van Pelt AM; van der Saag PT; Hoogerbrugge JW; Themmen AP; de Rooij DG
Endocrinology; 1997 Apr; 138(4):1544-51. PubMed ID: 9075714
[TBL] [Abstract][Full Text] [Related]
17. Retinoid x receptor agonists increase bcl2a1 expression and decrease apoptosis of naive T lymphocytes.
Rasooly R; Schuster GU; Gregg JP; Xiao JH; Chandraratna RA; Stephensen CB
J Immunol; 2005 Dec; 175(12):7916-29. PubMed ID: 16339527
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of the teratogenic effects induced by coadministration of retinoic acid or phytanic acid/phytol with synthetic retinoid receptor ligands.
Elmazar MM; Nau H
Arch Toxicol; 2004 Nov; 78(11):660-8. PubMed ID: 15558240
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma.
Waters AM; Stewart JE; Atigadda VR; Mroczek-Musulman E; Muccio DD; Grubbs CJ; Beierle EA
Mol Cancer Ther; 2015 Jul; 14(7):1559-69. PubMed ID: 25944918
[TBL] [Abstract][Full Text] [Related]
20. Reduced retinoid signaling in the skin after systemic retinoid-X receptor ligand treatment in mice with potential relevance for skin disorders.
Mihály J; Gericke J; Aydemir G; Weiss K; Carlsen H; Blomhoff R; Garcia J; Rühl R
Dermatology; 2012; 225(4):304-11. PubMed ID: 23296452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
